LuSeed Vascular

About

LuSeed Vascular is a medical technology startup founded in 2018 by Nitzan Hirsh and Amir Arthur, based in Israel. The company specializes in neurovascular innovation, focusing on developing devices to enhance treatment outcomes for brain aneurysms. The flagship product, the LuSeed DOME™, is a minimally invasive implant designed for treating bifurcation and sidewall brain aneurysms. Its unique geometry allows for intuitive and stable implantation, minimizing protrusion into the parent artery and reducing the need for long-term dual antiplatelet therapy. This device is compatible with robotic systems, aiming to standardize care for neurointerventional radiologists and improve patient outcomes. In addition to brain aneurysms, LuSeed Vascular is working on a pipeline of medical devices for cardiovascular and digestive system diseases. Their technology includes an active implant that promotes blood vessel closure, addressing various vascular pathologies. The company serves neurointerventional physicians and hospitals, focusing on safer and more effective treatment options.

Technologies

Outlook Microsoft Office 365 Android Airtable AI

Keywords

medical equipment manufacturing endovascular treatment dual-layered mesh design minimized protrusion intrasaccular device implant delivery system medical equipment and supplies manufacturing device safety profile innovative braided mesh short procedural time implantation technique services device geometry versatile aneurysm access healthcare technology long-term occlusion neurovascular innovation long-term safety enhancement rapid learning curve regulatory compliance medical device development b2b procedural efficiency medical devices agnostic positioning long-term patient safety ruptured aneurysm treatment flow diverter controlled deployment healthcare

About

Technologies

Keywords

Company Information

Related Companies